Literature DB >> 22171254

CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Melanie Schmid1, Ramon A Gonzalez, Thomas Dobner.   

Abstract

The life cycle of adenoviruses is divided by convention into early and late phases, separated by the onset of viral genome replication. Early events include virus adsorption, transport of the genome into the nucleus, and the expression of early genes. After the onset of viral DNA replication, transcription of the major late transcription unit (MLTU) and thereby synthesis of late proteins is induced. These steps are controlled by an orchestra of regulatory processes and require import of the genome and numerous viral proteins into the nucleus, as well as active transport of viral transcripts and proteins from the nucleus to the cytoplasm. The latter is achieved by exploiting the shuttling functions of cellular transport receptors, which normally stimulate the nuclear export of cellular mRNA and protein cargos. A set of adenoviral early and late proteins contains a leucine-rich nuclear export signal of the HIV-1 Rev type, known to be recognized by the cellular export receptor CRM1. However, a role for CRM1-dependent export in supporting adenoviral replication has not been established. To address this issue in detail, we investigated the impact of two different CRM1 inhibitors on several steps of the adenoviral life cycle. Inhibition of CRM1 led to a reduction in viral early and late gene expression, viral genome replication, and progeny virus production. For the first time, our findings indicate that CRM1-dependent shuttling is required for the efficient export of adenoviral early mRNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171254      PMCID: PMC3302419          DOI: 10.1128/JVI.06275-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  Adenovirus late gene expression does not require a Rev-like nuclear RNA export pathway.

Authors:  C Rabino; A Aspegren; K Corbin-Lickfett; E Bridge
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence.

Authors:  M Dobbelstein; J Roth; W T Kimberly; A J Levine; T Shenk
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

3.  The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2.

Authors:  F Krätzer; O Rosorius; P Heger; N Hirschmann; T Dobner; J Hauber; R H Stauber
Journal:  Oncogene       Date:  2000-02-17       Impact factor: 9.867

Review 4.  Adenovirus virus-associated RNA and translation control.

Authors:  M B Mathews; T Shenk
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88.

Authors:  M Fornerod; J van Deursen; S van Baal; A Reynolds; D Davis; K G Murti; J Fransen; G Grosveld
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

6.  The role of the adenovirus protease on virus entry into cells.

Authors:  U F Greber; P Webster; J Weber; A Helenius
Journal:  EMBO J       Date:  1996-04-15       Impact factor: 11.598

7.  RNA-binding properties of a translational activator, the adenovirus L4 100-kilodalton protein.

Authors:  D Riley; S J Flint
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells.

Authors:  U C Yang; W Huang; S J Flint
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  The metabolism of small cellular RNA species during productive subgroup C adenovirus infection.

Authors:  J K Smiley; M A Young; C C Bansbach; S J Flint
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

10.  Protein ligands to HuR modulate its interaction with target mRNAs in vivo.

Authors:  C M Brennan; I E Gallouzi; J A Steitz
Journal:  J Cell Biol       Date:  2000-10-02       Impact factor: 10.539

View more
  9 in total

Review 1.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

2.  RANBP2 and USP9x regulate nuclear import of adenovirus minor coat protein IIIa.

Authors:  Ashrafali M Ismail; Amrita Saha; Ji S Lee; David F Painter; Yinghua Chen; Gurdeep Singh; Gabriela N Condezo; James Chodosh; Carmen San Martín; Jaya Rajaiya
Journal:  PLoS Pathog       Date:  2022-06-16       Impact factor: 7.464

3.  Identification of Inhibitors and Drug Targets for Human Adenovirus Infections.

Authors:  Minli Liu; Lefang Jiang; Weihua Cao; Jianguo Wu; Xulin Chen
Journal:  Viruses       Date:  2022-05-04       Impact factor: 5.818

Review 4.  Emerging From the Unknown: Structural and Functional Features of Agnoprotein of Polyomaviruses.

Authors:  A Sami Saribas; Pascale Coric; Anahit Hamazaspyan; William Davis; Rachel Axman; Martyn K White; Magid Abou-Gharbia; Wayne Childers; Jon H Condra; Serge Bouaziz; Mahmut Safak
Journal:  J Cell Physiol       Date:  2016-02-24       Impact factor: 6.384

Review 5.  Viral subversion of the nuclear pore complex.

Authors:  Valerie Le Sage; Andrew J Mouland
Journal:  Viruses       Date:  2013-08-16       Impact factor: 5.048

6.  Nuclear export of human hepatitis B virus core protein and pregenomic RNA depends on the cellular NXF1-p15 machinery.

Authors:  Ching-Chun Yang; Er-Yi Huang; Hung-Cheng Li; Pei-Yi Su; Chiaho Shih
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

7.  CRM1 Promotes Capsid Disassembly and Nuclear Envelope Translocation of Adenovirus Independently of Its Export Function.

Authors:  Floriane Lagadec; Irene Carlon-Andres; Jessica Ragues; Sarah Port; Harald Wodrich; Ralph H Kehlenbach
Journal:  J Virol       Date:  2021-11-10       Impact factor: 5.103

8.  ValidNESs: a database of validated leucine-rich nuclear export signals.

Authors:  Szu-Chin Fu; Hsuan-Cheng Huang; Paul Horton; Hsueh-Fen Juan
Journal:  Nucleic Acids Res       Date:  2012-10-22       Impact factor: 16.971

9.  In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.

Authors:  Douglas G Widman; Savanna Gornisiewicz; Sharon Shacham; Sharon Tamir
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.